In pregnancy, which statement about vulvovaginal infections is accurate?

In pregnancy, which statement about vulvovaginal infections is accurate?

• A. Candidiasis is rare in pregnancy and hard to treat.
• B. BV in pregnancy has no impact on outcome.
• C. Candidiasis is common and treated with safe antifungals; BV in pregnancy is associated with preterm birth; treatments must be pregnancy-safe.
• D. All antifungal medications are contraindicated in pregnancy.

Answer: (C)

In pregnancy, vaginal infections behave differently because hormonal changes favor yeast overgrowth and alter vaginal flora. Candidiasis becomes common, and the best approach is to treat with antifungals that are safe for the fetus—typically topical azoles like clotrimazole or miconazole for several days. Systemic fluconazole is avoided during pregnancy due to potential fetal harm, especially in early pregnancy, so the emphasis is on pregnancy-safe topical therapy for yeast infections. Bacterial vaginosis in pregnancy is linked to adverse outcomes, most notably preterm birth, so it’s important to treat it with options that are considered safe in pregnancy—metronidazole or clindamycin are commonly used, and metronidazole is considered safe in pregnancy. This highlights why BV in pregnancy cannot be ignored as simply a nuisance; it has real implications for pregnancy outcomes. Overall, not all antifungals are contraindicated in pregnancy—topical antifungals are generally safe, while some systemic agents carry risks. The statement that candidiasis is common and treated with safe antifungals, and that BV is associated with preterm birth and requires pregnancy-safe treatment, best reflects current practice.

In pregnancy, vaginal infections behave differently because hormonal changes favor yeast overgrowth and alter vaginal flora. Candidiasis becomes common, and the best approach is to treat with antifungals that are safe for the fetus—typically topical azoles like clotrimazole or miconazole for several days. Systemic fluconazole is avoided during pregnancy due to potential fetal harm, especially in early pregnancy, so the emphasis is on pregnancy-safe topical therapy for yeast infections.

Bacterial vaginosis in pregnancy is linked to adverse outcomes, most notably preterm birth, so it’s important to treat it with options that are considered safe in pregnancy—metronidazole or clindamycin are commonly used, and metronidazole is considered safe in pregnancy. This highlights why BV in pregnancy cannot be ignored as simply a nuisance; it has real implications for pregnancy outcomes.

Overall, not all antifungals are contraindicated in pregnancy—topical antifungals are generally safe, while some systemic agents carry risks. The statement that candidiasis is common and treated with safe antifungals, and that BV is associated with preterm birth and requires pregnancy-safe treatment, best reflects current practice.